RVTY (PerkinElmer) יחס שווי שוק לשווי בספרים
Revvity, Inc. (RVTY) has completed a large-scale spin-off, focusing on organically increasing margins and integrating assets. The market-to-book ratio illustrates this search for equilibrium, with the metric currently standing at 2.48. The transformation into the life-science sector with an emphasis on reagents creates a foundation for growth. Stability is ensured by the supply of software and equipment to global clinics and institutions.
%20-%20%D7%99%D7%97%D7%A1%20%D7%A9%D7%95%D7%95%D7%99%20%D7%A9%D7%95%D7%A7%20%D7%9C%D7%A0%D7%9B%D7%A1%D7%99%D7%9D%20%D7%A0%D7%A7%D7%99%D7%99%D7%9D&width=1200&height=400&colorIndex=0&v=mvq8bmkb.8d-7aozthc&start=20220704&end=20261027&filename=GURU_Markets_-_RVTY_-_Revvity-Inc._-_Market-Cap-to-Net-Assets-Ratio "RVTY יחס שווי שוק לערך בספרים Revvity (21.02.2024 - 27.10.2026) | 👁️GURU.Markets👁️")
פילוחי מדדים פיננסיים ומדדי שוק עבור Revvity Inc (RVTY)
Revvity, Inc. (RVTY) is strengthening its leadership in biomedicine through the integration of IT services and diagnostic alliances, creating high added value for its assets. The market-to-book ratio digitizes this premium, demonstrating the extent to which the market values business synergies above its book value, which allows the premium of the market valuation over the balance sheet to distinguish fundamental growth from a value trap.